Skip to main content
. 2022 May 20;13(5):12309–12325. doi: 10.1080/21655979.2022.2072619

Figure 2.

Figure 2.

miR-744-5p is closely related to the clinical features of patients with OS. (a) Lower expression of miR-744-5p was found in the middle and advanced stage of OS compared to the early stage. (b) Lower expression of miR-744-5p was related to larger tumors. (c) Lower expression of miR-744-5p was found in more patients with metastasis. (d) Log-Rank test demonstrated that patients with higher miR-744-5p expression had a better prognosis. * p < 0.05, ** p < 0.01, *** p < 0.001.